Company Description
Privia Health Group, Inc. operates as a national physician-enablement company in the United States.
The company collaborates with physician practices, health plans, and health systems. It offers technology and population health tools to enhance providers’ workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives.
The company also operates accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts.
The company was founded in 2007 and is headquartered in Arlington, Virginia.
| Country | United States |
| Founded | 2007 |
| IPO Date | Apr 29, 2021 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 1,140 |
| CEO | Parth Mehrotra |
Contact Details
Address: 950 North Glebe Road, Suite 700 Arlington, Virginia 22203 United States | |
| Phone | 571 366 8850 |
| Website | priviahealth.com |
Stock Details
| Ticker Symbol | PRVA |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $23.00 |
| CIK Code | 0001759655 |
| CUSIP Number | 74276R102 |
| ISIN Number | US74276R1023 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Parth Mehrotra | Chief Executive Officer and Director |
| David Mountcastle CPA, MBA | Executive Vice President, Chief Financial Officer and Principal Accounting Officer |
| Edward Christopher Fargis Esq. | Executive Vice President, General Counsel, Chief Legal Officer and Corporate Secretary |
| Sarath Degala | Chief Operating Officer |
| Chris Voigt | Executive Vice President and Chief Technology Officer |
| Robert P. Borchert | Senior Vice President of Investor Relations and Corporate Communications |
| Jenny Harding | Chief People Officer |
| Jay Stevens | Senior Vice President and Chief Growth Officer |
| Eric J. Beyer | Executive Vice President of Medical Groups |
| Dr. Keith Fernandez M.D. | Executive Vice President and Chief Clinical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 4, 2025 | ARS | Filing |
| Apr 4, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 4, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 2, 2025 | 144 | Filing |
| Mar 12, 2025 | 144 | Filing |
| Mar 11, 2025 | 144 | Filing |
| Mar 11, 2025 | 144 | Filing |
| Mar 11, 2025 | 144 | Filing |
| Mar 10, 2025 | 144 | Filing |
| Mar 10, 2025 | 144 | Filing |